STIMULANT USE DISORDER

Clinical trials for STIMULANT USE DISORDER explained in plain language.

Never miss a new study

Get alerted when new STIMULANT USE DISORDER trials appear

Sign up with your email to follow new studies for STIMULANT USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 3 Not yet finished but already full! 3 Completed 3 Terminated 1

Magic mushroom compound studied for meth addiction safety

Symptom relief Terminated

This early-stage study looked at whether psilocybin, the active ingredient in magic mushrooms, is safe and practical to use alongside behavioral support for people with methamphetamine use disorder. Only 5 participants were enrolled before the study ended early. The main goal was…

Matched conditions: STIMULANT USE DISORDER

Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief

Last updated May 15, 2026 11:53 UTC

STIMULANT USE DISORDER

Get alerted when new STIMULANT USE DISORDER trials appear

Magic mushroom compound studied for meth addiction safety